About: Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1996 (uk) article scientifique publié en 1996 (fr) im September 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1996 (ast) scientific article published on 01 September 1996 (en)
publication date	wds:Q71732644-6AED84C6-5584-4214-A2CB-209EB9DFA2BB
publication date	1996-09-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q71732644-0ABCB74E-AEBD-4A5D-A549-2DF5B18F8F3E wds:Q71732644-11B4856F-CF52-4B13-962C-5ECA7A530777 wds:Q71732644-128A014D-9A92-49B2-A09C-9BAFBF6A10A7 wds:Q71732644-2B76416C-4883-4107-B6A2-26ADD76CC98C wds:Q71732644-398790CE-630C-4822-BAEB-7F900085789B wds:Q71732644-44F4417D-9C44-487B-9BC5-BA820CDC39DD wds:Q71732644-48B492C0-3472-452F-85D4-A1B470658182 wds:Q71732644-5412EC21-C092-4A79-A469-D042B50C23F0 wds:Q71732644-628BED47-116E-440B-8146-0CBF233947B7 wds:Q71732644-68935301-8960-4C65-BCD3-248B23FE1FC6 wds:Q71732644-742F6C82-2133-4FFA-9C64-1C0199C32D67 wds:Q71732644-7B138ECA-1AB2-4C08-A461-7D25760B4B7D wds:Q71732644-7D8E3D07-9AD4-4C64-BD08-47C71398DDEA wds:Q71732644-8886E2E8-E9B0-4C14-9744-FCFC5888D9D4 wds:Q71732644-8E38C0C6-C429-4F40-B144-1171231B8BE2 wds:Q71732644-A5E6B3EB-AA63-4C95-9E57-B5B0E586C991 wds:Q71732644-ABE8C8B5-2391-4D1E-BABA-D0B5999D2C05 wds:Q71732644-AEF2521F-C83D-4E73-88CD-ADB5DFCA38C4 wds:Q71732644-B0FF67B1-A8C2-4374-9645-E8A759F967C7 wds:Q71732644-B2C51813-3941-4CE9-BAA0-A6D2E42A74AB wds:Q71732644-BF39115D-02DB-4B25-938F-E95C9ECF25CF wds:Q71732644-C948BFB9-3563-40FF-8889-98C0B3A1739E wds:Q71732644-CB56DED0-DB90-4863-85BC-E6F0D7F0A106 wds:Q71732644-CC681E19-E623-4F93-8040-775144C6E9E0 wds:Q71732644-CCF38366-8111-414B-A960-FC84BFE0852B wds:Q71732644-D5A7B024-241C-41EC-9F85-AF480A04CB56 wds:Q71732644-E787C86B-6BD9-4930-8586-E48624C07CB2 wds:Q71732644-F7901E0F-13CF-41E8-9EE1-3585FB9FC8CB
cites work	Clinical outcomes after transfusion-associated hepatitis C. A pilot study of ribavirin therapy for chronic hepatitis C Non-A, non-B post-transfusion hepatitis. Looking back in the second decade Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group Ribavirin treatment for chronic hepatitis C N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. Interferon for non-A, non-B chronic hepatitis Long-term follow-up of patients with chronic hepatitis C treated with α-interferon Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Response to interferon alpha therapy is influenced by the iron content of the liver An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Chronic viral hepatitis B and C: an argument against the conventional classification of chronic hepatitis Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trial Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A,non-B viral hepatitis. A randomized controlled trial HCV RNA in patients with chronic hepatitis C treated with interferon-alpha Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon
author name string	wds:Q71732644-0521359E-9DBD-480D-AB86-29E0EA1D5918 wds:Q71732644-211CBD74-366E-4638-9A62-3A248CFD5C5A wds:Q71732644-4697BDA1-74EC-448E-9124-5CA22298B430 wds:Q71732644-817D2BFE-B43E-4C6F-9E17-ACC6261BDE31 wds:Q71732644-82459E67-09A2-4BCA-9396-DCC986DB6F36 wds:Q71732644-A3358715-7316-4CDB-8C45-99DA40C14601 wds:Q71732644-AF2D511A-00F0-43F3-9AE5-2E79729DE603 wds:Q71732644-BBA66C09-73DF-4438-A98E-0545E0600F12 wds:Q71732644-DB69273F-FF70-451A-AF4C-4900399A3E07 wds:Q71732644-EA32D4A3-6DD7-4530-A3BA-6DB9671E68A7
author name string	M Schmid A Zimmermann H Bühler J Reichen L Bianchi D Lavanchy E L Renner P J Malé J J Gonvers N Dolivo
rdfs:label	Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver (en) Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver (nl)
skos:prefLabel	Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver (en) Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver (nl)
name	Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver (en) Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver (nl)
author	wds:Q71732644-7519455C-B751-4510-B449-7F9E9F4D9823
author	Marc Solioz
title	wds:Q71732644-5944A6AB-1110-4BAE-B2CC-6D6A89153F13
title	Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver (en)
page(s)	wds:Q71732644-319E9DB0-70AC-4947-BD35-EF6BD67B9654
page(s)	275-282
instance of	wds:Q71732644-AE9C34E2-1187-492E-8D93-70C5BE409B1E
instance of	scholarly article
main subject	wds:Q71732644-9342CC27-2CD5-4A85-BFC4-2A66F6A50DD0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software